LWAC
ELV icon

Laurel Wealth Advisors (California)’s Elevance Health ELV Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$683K Sell
1,332
-16
-1% -$8.12K 0.07% 292
2022
Q3 		$612K Sell
1,348
-11
-0.8% -$5.26K 0.07% 305
2022
Q2 		$656K Sell
1,359
-412
-23% -$204K 0.07% 299
2022
Q1 		$870K Sell
1,771
-21
-1% -$9.6K 0.07% 269
2021
Q4 		$831K Sell
1,792
-2
-0.1% -$841 0.06% 313
2021
Q3 		$669K Buy
1,794
+18
+1% +$6.84K 0.12% 194
2021
Q2 		$678K Sell
1,776
-247
-12% -$94.4K 0.09% 224
2021
Q1 		$726K Sell
2,023
-23
-1% -$7.4K 0.11% 192
2020
Q4 		$657K Buy
2,046
+40
+2% +$12.3K 0.1% 200
2020
Q3 		$539K Buy
2,006
+246
+14% +$66.2K 0.09% 215
2020
Q2 		$463K Buy
1,760
+247
+16% +$65.9K 0.08% 230
2020
Q1 		$344K Sell
1,513
-1
-0.1% -$273 0.08% 255
2019
Q4 		$457K Buy
1,514
+6
+0.4% +$1.65K 0.08% 269
2019
Q3 		$362K Sell
1,508
-117
-7% -$32.1K 0.06% 308
2019
Q2 		$459K Buy
1,625
+127
+8% +$34.7K 0.1% 222
2019
Q1 		$430K Sell
1,498
-79
-5% -$22.8K 0.11% 211
2018
Q4 		$414K Buy
1,577
+6
+0.4% +$1.65K 0.12% 194
2018
Q3 		$430K Sell
1,571
-9
-0.6% -$2.34K 0.11% 215
2018
Q2 		$376K Hold
1,580
– – 0.1% 217
2018
Q1 		$347K Buy
1,580
+11
+0.7% +$2.58K 0.11% 215
2017
Q4 		$353K Buy
1,569
+12
+0.8% +$2.56K 0.1% 222
2017
Q3 		$295K Buy
+1,557
New +$296K 0.1% 219

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Laurel Wealth Advisors (California)'s ELV Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Elevance Health (ELV) stake by 1.2% in Q4 2022, selling an estimated $8.12K and leaving 1,332 shares worth $683K. The position accounts for 0.07% of the portfolio, ranked #292.

Laurel Wealth Advisors (California) first reported a position in ELV in Q3 2017 and has held it in 22 quarters since. The position peaked at $870K in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Laurel Wealth Advisors (California) held 1,332 shares of Elevance Health worth $683K as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 16 Elevance Health shares in Q4 2022, an estimated $8.12K.
  • Elevance Health made up 0.07% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #292 holding.
  • Laurel Wealth Advisors (California) first reported a position in Elevance Health in Q3 2017 and has held it in 22 quarters since.
  • Laurel Wealth Advisors (California)'s Elevance Health position peaked at $870K in Q1 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.